AQR Capital Management
AMPE

AQR Capital Management’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

AQR Capital Management’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-501
Closed -$71K – 2337
2022
Q1 		$71K Sell
501
-131
-21% -$19.1K ﹤0.01% 2167
2021
Q4 		$108K Buy
632
+432
+216% +$161K ﹤0.01% 2141
2021
Q3 		$100K Buy
+200
New +$92.7K ﹤0.01% 2201
2018
Q3 		– Sell
-203
Closed -$134K – 2353
2018
Q2 		$134K Buy
+203
New +$152K ﹤0.01% 2271
2014
Q3 		– Sell
-187
Closed -$469K – 2617
2014
Q2 		$469K Hold
187
– – ﹤0.01% 2017
2014
Q1 		$357K Buy
+187
New +$442K ﹤0.01% 2189

Other funds holding AMPE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $3.54B AUM 19.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management's AMPE Position: Q2 2022 in Review

AQR Capital Management sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q2 2022, closing a stake of 501 shares — an estimated $71K sold.

AQR Capital Management first reported a position in AMPE in Q1 2014 and held it in 6 quarters. The position peaked at $469K in Q2 2014. 111 funds tracked by Wall St. Rank hold AMPE as of Q2 2022.

  • AQR Capital Management reported no remaining Ampio Pharmaceuticals Inc. position as of Q2 2022 after selling out during the quarter.
  • AQR Capital Management sold 501 Ampio Pharmaceuticals Inc. shares in Q2 2022, an estimated $71K.
  • AQR Capital Management first reported a position in Ampio Pharmaceuticals Inc. in Q1 2014 and held it in 6 quarters.
  • AQR Capital Management's Ampio Pharmaceuticals Inc. position peaked at $469K in Q2 2014.
  • 111 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q2 2022.

Based on AQR Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.